AzTrials
AzTrials

CHD - Coronary Heart DiseaseNCT03744650

mHealth Lifestyle Intervention on CHD Primary Prevention

A study testing "Care4Heart" programme in people with CHD - Coronary Heart Disease and Health Knowledge, Attitudes, Practice, run by National University of Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Coronary heart disease (CHD), the most prevalent type of cardiovascular disease among adults, has been identified as one of the chronic diseases which are epidemic in the world. Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
What is being tested?
"Care4Heart" programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
No sites listed yet
Study dates
1 Nov 2014to 30 Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • working full-time;
  • aged between 21-65 years;
  • use a smartphone (e.g. Samsung, iPhone) in their daily lives frequently; and
  • able to read, speak and understand English.

Who cannot join

  • have a clinical diagnosis of CHD or other heart diseases (e.g. congestive heart failure);
  • work in a health-relevant school/department/environment (e.g. school of medicine, school of public health, department of dentistry, school of pharmacy; university health centre); and
  • have reading difficulties.

About this study

Official title: Improving Awareness, Knowledge and Heart-related Lifestyle of Coronary Heart Disease Among Working Population Through a mHealth Programme

Background: Coronary heart disease (CHD), the most prevalent type of cardiovascular disease among adults, has been identified as one of the chronic diseases which are epidemic in the world. Teaching and encouraging the working population to adopt a healthier lifestyle could favor in preventing and/or decreasing the incidence of CHD among this population. The use of mobile application (app) is the next logical wave of healthcare support tools to prevent and manage chronic diseases like CHD.

Aims: The aims of the study are to develop a mHealth programme, entitled "Care4Heart" for the working population in Singapore, and thereafter examine its feasibility and effectiveness in increasing the awareness and knowledge of coronary heart disease (CHD) as well as improving their heart-related lifestyle.

Read more

Methods: A two-phase study design will be adopted. Phase 1 is a pilot, two-arm randomized controlled trial (RCT) study and phase 2 is a single group pretest and repeated posttest longitudinal study. The study will be conducted in National University of Singapore. A convenience sampling will be used, and a total of 240 healthy working adults will be recruited via posters advertising in campus canteens, which comprising 80 participants in Phase 1 and 160 participants in Phase 2 study. The first recruited 80 participants will be randomly allocated to an intervention group and a control group, and only those in the intervention group will receive 4-week "Care4Heart" programme. For the participants recruited in phase 2 (n = 160), the newly developed mobile app will be installed onto their' smartphones, and a well-trained research assistant will brief the participants about the utilization of the app.

The main outcomes will be measured using the survey questionnaires: Awareness of CHD, Heart Disease Fact Questionnaire-2, Behavioral Risk Factor Surveillance System and Perceived Stress Scale. Data will be collected at baseline, and at the 4th week for phase 1 study while a third data collection at the 6th month thereafter will be conducted for phase 2 participants. Data will be analyzed using IBM SPSS 22.0.

Applications: If this project is proved to be feasible and effective, "Care4Heart" app, a novel CHD prevention programme will be popularized nationwide to promote knowledge and elicit positive heart-related behavioral changes for the working population in Singapore

Read the detailed description

The study aims to develop a mHealth programme, entitled "Care4Heart" for the working population in Singapore and examine its feasibility and effectiveness in increasing the awareness and knowledge of coronary heart disease (CHD) as well as improving their heart-related lifestyle.

The objectives are:

  1. To develop a mHealth programme using the smartphone app, entitled "Care4Heart" for the working population in Singapore to assist them in establishing a healthy lifestyle.
  2. To test the effectiveness of the "Care4Heart" app in increasing the awareness and knowledge of CHD among the working population in Singapore.
  3. To test the effectiveness of the "Care4Heart" app in eliciting a positive heart-related lifestyle modification, including stress reduction among the working population in Singapore.

Background Deaths caused by CHD are often preventable. Deranged serum lipid profile, hypertension, obesity, physical inactivity and excess working stress are the well-known preventable risk factors of CHD, and the reduction of these risk factors will improve physical and psychological health and prevent future adverse and fatal cardiac events. Sedentary lifestyles and unhealthy diets are common reasons that may predispose Singaporeans to the risk of developing CHD, especially the majority of the workforce working in offices who engage in little or no physical activity. It was reported that about 40% of the working population (i.e. 21 to 65 years old) in Singapore do not engage in regular physical exercise. The increasing popularity of high fat diet and eating out and the high levels of stress experienced by the working population may further increase their risk of developing CHD.

Many of risk factors of CHD are modifiable and can be greatly reduced by adopting a healthy lifestyle. Exercising regularly and following a healthy diet plan are effective strategies in lowering cardiovascular risk factors. Obviously there is a need for an updated educational programme aimed at teaching and encouraging people in the working population to adopt a healthier lifestyle, which would result in them changing their behaviours and sustaining a healthy lifestyle to reach optimal health. Even though, health promotion programmes including the traditional face-to-face cardiac education sessions have been developed to be accessed by the general population, a known barrier for not reaching the working population is the lack of time as a result of long work hours. With a substantial increase in the number of people owning smartphones and a sharp increase in the usage of smartphones in recent years, the smartphone is a device most people in Singapore own. Recently the Infocomm Development Authority of Singapore (2013) announced plans for a well-connected mobile network to support major industries including healthcare. Hence the promotion of mobile health (mHealth) is the next logical wave of healthcare support tools to prevent and manage chronic diseases like CHD. A recent whitepaper based on market research conducted in Singapore reported that about 92% of Singaporeans aged between 25 to 39 years owned smartphones. While 83% of the older population aged from 55 years onwards owned smartphones as well. Based on this report, it is widely expected that mHealth will reach many Singaporeans as tools to maintain and improve their health.

Over the past few decades, more innovative ways for the design and delivery of primary/secondary prevention programme have been developed due to the rapid evolution of technology. One such programme used increasingly in the prevention and management of chronic diseases is mHealth which includes web-based programmes and smartphone applications (apps). Several studies conducted in Western countries reported on the effectiveness of mHealth in improving self-management skills and increasing healthy behaviours of individuals with chronic disease, such as diabetes, hypertensionand CHD. More importantly, apps are more accessible and convenient, enabling the information to reach more people by overcoming obstacles such as physical distance to attend a face-to face education session. However, these apps that have been developed are not completely relevant and suitable for Singaporeans because of significant cultural and economic differences that influence cardiac risk factors. For example the diet in Singapore and the culture of longer working hours are significantly different from Western countries.

Design/Methodology This study was funded by a grant from Singapore Heart Foundation (Grant Number: RG2013/02). A two-phase study design will be adopted. Phase 1 is a pilot, two-arm RCT study and phase 2 is a single group repeated test longitudinal study. The data of Phase1 study will be collected at the baseline and 4th week. The Phase 2 data will be collected at the baseline, 4th week and 6th months from the baseline.

Participants

The target population for this study is the working population in Singapore. The study will be conducted in National University of Singapore. A total of 240 convenient samples will be recruited via posters advertising in campus canteens, comprising 80 subjects in Phase 1 and 160 subjects in Phase 2 study. The first recruited 80 participants will be randomly allocated to an intervention group or a control group.

Phase 1 Randomization All eligible participants will be assigned a unique case number according to the sequence in which participants are recruited, for example, the first eligible participant will be assigned the number of one, and the second eligible assigned the number of two and so on. A total of 40 numbers without any duplicates will be randomly generated, from 1 to 80, using SPSS. Participants whose assigned numbers matched the numbers generated by the software will be allocated into the intervention group; otherwise, the participant will be assigned to the control group.

Theoretical rationale for intervention According to the Health Belief Model, there are several factors which influence health outcomes of an individual. These factors are: (1) the individual's belief that there is a threat to his/her health because of the illness, (2) the level of motivation of the individual to take action to improve his/her health and (3) the individual's belief that the intervention recommended will decrease the threat to his/her health. These factors will be addressed in our proposed "Care4Heart" mHealth programme which will cover the CHD risk factors, the possible health-threatening outcomes and strategies to decrease these risk factors are provided.

Intervention A 4-week mHealth programme in the form of a smartphone app, named "Care4Heart", has been developed. The content and scope of the design are developed by a thorough literature review and an extensive analysis of existing education leaflets and brochures used to prevent CHD. The contents are specified and tailored to the working population.

The app is developed by a team of software engineers from Computing School of NUS. Several functions include: (1) app using instructional video; (2) easy-to-read information on healthy lifestyle toward heart health, including information about the disease, CHD risk factors (e.g. diet, smoking cessation), stress, physical exercises and relaxation techniques; and (3) scheduled reminders for doing exercise and relaxation.

A website (www.care4heart.sg) has been created as well. Participants are allowed to visit the website for the details about this project and research team members.

Study procedure

Phase 1: Pilot RCT One face-to-face briefing session will be offered for the 40 participants allocated to the intervention group after the consent is obtained. The smartphone app will be installed to the participant's own smartphone, and one of the research team members will brief the participant on the utilization of app. This session will take about 20 to 30 minutes. After participants are familiar with the setup and the structure of the app, the participants will be expected to spend 15-20 minutes every day to go through all the educational content in 4 weeks' time. The participants will also be encouraged to change their lifestyle to modify their cardiac risk factors according to the information given in the app, for example engaging in regular exercise, and practicing relaxation.

No intervention will be provided to the participants in the control group. Data will be collected online. Participants can complete the questionnaires on the website (www.care4heart.sg). All data will be electronically stored in an encrypted and password accessed-only computer database, in accordance to the University's Research Data Management Policy.

The above questionnaires will be completed at two time points; (1) upon giving consent to participate in the study (baseline), and (2) at the 4th week.

Phase 2: single group pretest and repeated posttest longitudinal study A total of 160 participants will be recruited for phase 2 study. The same as phase 1 study, One face-to-face briefing session will be offered for all participants after the consent is obtained. The smartphone app will be installed to the participant's own smartphone, and one of the research team members will brief the participant on the utilization of app. This session will take about 20 to 30 minutes. . After participants are familiar with the setup and the structure of the app, the participants will be expected to spend 15-20 minutes every day to go through all the educational content in 4 weeks' time. The participants will also be encouraged to change the lifestyle to modify their cardiac risk factors according to the information given in the app, for example engaging in regular exercise, and practicing relaxation.

Data will be collected online. Participants can complete the questionnaires on the website (www.care4heart.sg). All data will be electronically stored in an encrypted and password accessed-only computer database, in accordance to the University's Research Data Management Policy.

The above questionnaires will be completed at three time points; (1) upon giving consent to participate in the study (baseline); (2) at the 4th week from the baseline; and. (3) at the 6th month follow-up period.

Data analysis All data obtained will be analyzed using IBM SPSS 22.0 (Armonk, NY, USA). Descriptive statistics, including the frequency distribution, mean and standard deviation will be used to describe the social-demographic and anthropometric data, HDFQ-2, BRFSS and PSS-10 of all participants. In Phase 1 study, significant differences in the change scores of HDFQ-2, BRFSS and PSS-10 will be examined via paired samples t-test and between-group changes will be examined via independent t-test. In Phase 2 study, significant differences in the change scores of HDFQ-2, BRFSS and PSS-10 will be examined via paired samples t-test. The level of significance selected for this study is set at p = 0.05, indicating a 5% of committing a Type I error. The Bonferroni posthoc test will be run to reduce the likelihood of identifying the difference by chance.

Being tested
"Care4Heart" programme
Keywords
Pirmary prevention, Coronary Heart Disease, mHealth
Medical subject headings
Coronary Artery Disease, Behavior, Health Behavior, Coronary Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "Care4Heart" programmeBehavioural

    A 4-week mHealth programme in the form of a smartphone app, named "Care4Heart", has been developed. The content and scope of the design are developed by a thorough literature review and an extensive analysis of existing education leaflets and brochures used to prevent CHD. The contents are specified and tailored to the working population.

    The app is developed by a team of software engineers from Computing School of NUS. Several functions include: (1) app using instructional video; (2) easy-to-read information on healthy lifestyle toward heart health, including information about the disease, CHD risk factors (e.g. diet, smoking cessation), stress, physical exercises and relaxation techniques; and (3) scheduled reminders for doing exercise and relaxation

Study groups in NCT03744650
Study groupRoleWhat they receive
"Care4Heart" programmeExperimentalThe single group pretest and repeated posttest longitudinal study design is adopted in the main study. All the recruited participants received the study intervention
Receives: Behavioral: "Care4Heart" programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Awareness of Coronary Heart Disease

    Questions that assess participants' awareness of CHD in Singapore will be developed based on the statistic facts of CHD in Singapore, for example: (1) the percentage of deaths by CHD in Singapore; and (2) the second leading cause of death in Singapore

    Measured: baseline

  2. Awareness of Coronary Heart Disease

    Questions that assess participants' awareness of CHD in Singapore will be developed based on the statistic facts of CHD in Singapore, for example: (1) the percentage of deaths by CHD in Singapore; and (2) the second leading cause of death in Singapore

    Measured: 4th week from the baseline

  3. Awareness of Coronary Heart Disease

    Questions that assess participants' awareness of CHD in Singapore will be developed based on the statistic facts of CHD in Singapore, for example: (1) the percentage of deaths by CHD in Singapore; and (2) the second leading cause of death in Singapore

    Measured: 6th months from the baseline

Secondary outcomes (9)
  1. Heart Disease Fact Questionnaire-2 (HDFQ-2)

    Heart Disease Fact Questionnaire-2 (HDFQ-2) is a 25-item measure contains true/false questions that were developed to assess participants' knowledge of major risk factors for the development of CHD. Each true/false question that was correctly answered was scored as 4 points, for a maximum possible score of 100, indicting a higher level of knowledge. Any questions that were either unanswered or unsure were scored as incorrect. The HDFQ-2 has demonstrated adequate internal consistency with Cronbach alpha of 0.84 and good test-rested reliability with intraclass correlation coefficient (ICC) of 0.89.

    Measured: baseline

  2. Heart Disease Fact Questionnaire-2 (HDFQ-2)

    Heart Disease Fact Questionnaire-2 (HDFQ-2) is a 25-item measure contains true/false questions that were developed to assess participants' knowledge of major risk factors for the development of CHD. Each true/false question that was correctly answered was scored as 4 points, for a maximum possible score of 100, indicting a higher level of knowledge. Any questions that were either unanswered or unsure were scored as incorrect. The HDFQ-2 has demonstrated adequate internal consistency with Cronbach alpha of 0.84 and good test-rested reliability with intraclass correlation coefficient (ICC) of 0.89.

    Measured: 4th week from the baseline

  3. Heart Disease Fact Questionnaire-2 (HDFQ-2)

    Heart Disease Fact Questionnaire-2 (HDFQ-2) is a 25-item measure contains true/false questions that were developed to assess participants' knowledge of major risk factors for the development of CHD. Each true/false question that was correctly answered was scored as 4 points, for a maximum possible score of 100, indicting a higher level of knowledge. Any questions that were either unanswered or unsure were scored as incorrect. The HDFQ-2 has demonstrated adequate internal consistency with Cronbach alpha of 0.84 and good test-rested reliability with intraclass correlation coefficient (ICC) of 0.89.

    Measured: 6th months from the baseline

  4. Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire

    Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire was developed to provide a way to track cardiovascular risk factors. It contains 20 questions to assess participants' heart-related lifestyle status including exercise, cholesterol, tobacco use, alcohol consumption, and exercise activity. Findings form a recent systematic literature review of published articles from 2004 to 2011 detailing the test of reliability and validity of BRFSS indicated that the questionnaire has good reliability and validity.

    Measured: baseline

  5. Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire

    Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire was developed to provide a way to track cardiovascular risk factors. It contains 20 questions to assess participants' heart-related lifestyle status including exercise, cholesterol, tobacco use, alcohol consumption, and exercise activity. Findings form a recent systematic literature review of published articles from 2004 to 2011 detailing the test of reliability and validity of BRFSS indicated that the questionnaire has good reliability and validity.

    Measured: 4th week from the baseline

  6. Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire

    Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire was developed to provide a way to track cardiovascular risk factors. It contains 20 questions to assess participants' heart-related lifestyle status including exercise, cholesterol, tobacco use, alcohol consumption, and exercise activity. Findings form a recent systematic literature review of published articles from 2004 to 2011 detailing the test of reliability and validity of BRFSS indicated that the questionnaire has good reliability and validity.

    Measured: 6th months from the baseline

  7. Perceived Stress Scale-10 item (PSS-10)

    Perceived Stress Scale (PSS-10) is the most widely used instrument for measuring an individual's perception of the stress. The PSS consists of 10 items using a 5-point Liker scale with the higher the score indicating higher level of stress. It has been translated into different languages and the reliability and validity of the scale have been well established with Cronbach alpha greater than 0.80 being reported by majority of the studies.

    Measured: baseline

  8. Perceived Stress Scale-10 item (PSS-10)

    Perceived Stress Scale (PSS-10) is the most widely used instrument for measuring an individual's perception of the stress. The PSS consists of 10 items using a 5-point Liker scale with the higher the score indicating higher level of stress. It has been translated into different languages and the reliability and validity of the scale have been well established with Cronbach alpha greater than 0.80 being reported by majority of the studies.

    Measured: 4th week from the baseline

  9. Perceived Stress Scale-10 item (PSS-10)

    Perceived Stress Scale (PSS-10) is the most widely used instrument for measuring an individual's perception of the stress. The PSS consists of 10 items using a 5-point Liker scale with the higher the score indicating higher level of stress. It has been translated into different languages and the reliability and validity of the scale have been well established with Cronbach alpha greater than 0.80 being reported by majority of the studies.

    Measured: 6th months from the baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2018
  2. Study start1 Nov 2014
  3. Primary completion30 Apr 2017
  4. Study completion30 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
A two-phase study design will be adopted. Phase 1 is a pilot, two-arm randomized controlled trial (RCT) study and phase 2 is a single group pretest and repeated posttest longitudinal study.
Masking
None (open label)
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03744650
Sponsor's protocol ID
B-15-059
Status last verified
Nov 2018
First submitted
13 Nov 2018
Last updated
20 Nov 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Andreou E, Alexopoulos EC, Lionis C, Varvogli L, Gnardellis C, Chrousos GP, Darviri C. Perceived Stress Scale: reliability and validity study in Greece. Int J Environ Res Public Health. 2011 Aug;8(8):3287-98. doi: 10.3390/ijerph8083287. Epub 2011 Aug 11.

    PubMed 21909307
  • Awad A, Al-Nafisi H. Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey. BMC Public Health. 2014 Nov 4;14:1131. doi: 10.1186/1471-2458-14-1131.

    PubMed 25367768
  • Beatty AL, Fukuoka Y, Whooley MA. Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J Am Heart Assoc. 2013 Nov 1;2(6):e000568. doi: 10.1161/JAHA.113.000568. No abstract available.

    PubMed 24185949
  • Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, Oldenburg BF, Peach HG, Ruth D, Tennant CC, Tonkin AM. "Stress" and coronary heart disease: psychosocial risk factors. Med J Aust. 2003 Mar 17;178(6):272-6. doi: 10.5694/j.1326-5377.2003.tb05193.x.

    PubMed 12633484
  • Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011 Sep 22;13(3):e65. doi: 10.2196/jmir.1874.

    PubMed 21979293
  • Chyun D, Lacey KO, Katten DM, Talley S, Price WJ, Davey JA, Melkus GD. Glucose and cardiac risk factor control in individuals with type 2 diabetes: implications for patients and providers. Diabetes Educ. 2006 Nov-Dec;32(6):925-39. doi: 10.1177/0145721706295016.

    PubMed 17102160
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PubMed 6668417
  • Fleg JL, Forman DE, Berra K, Bittner V, Blumenthal JA, Chen MA, Cheng S, Kitzman DW, Maurer MS, Rich MW, Shen WK, Williams MA, Zieman SJ; American Heart Association Committees on Older Populations and Exercise Cardiac Rehabilitation and Prevention of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic He. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation. 2013 Nov 26;128(22):2422-46. doi: 10.1161/01.cir.0000436752.99896.22. Epub 2013 Oct 28. No abstract available.

    PubMed 24166575
  • Gough D. (2011). Coronary heart disease. Practice Nurse 41(1), 12-17

  • Ghanem F.A., & Movahed A. (2009). Prevention of Coronary Heart Disease. In Movahed, A., Gnanasegaran, G., Buscombe, J., & Hall, M. Integrating Cardiology for Nuclear Medicine Physicians. Springer Berlin Heidelberg. P. 419-423.

  • Centres of Disease Control and Prevention (2013). Behavioural Risk Factors Surveillance System Questionnaire. Retrieved from http://www.cdc.gov/brfss. Oct. 2013.

  • Ministry of Health (2014). Health Matters. Retrieved from ttp://mohsingapore.sg/2012/02/living-healthily/ January. 2014.

  • Infocomm Development Authority of Singapore (2013). iN2015 Masterplan. Retrieved from: http://www.ida.gov.sg/Infocomm-Landscape/iN2015-Masterplan on 01 February 2014.

  • Ministry of Health Singapore (2014). Principal Causes of Death 2013; Available from: http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html.

  • Polit D. F., & Beck C. T (2014). Essentials of Nursing Research: Methods, Appraisal, and Utilization. 8th edn. Philadelphia: Lippincott.

Questions about this trial

What is this clinical trial studying?

A study testing "Care4Heart" programme in people with CHD - Coronary Heart Disease and Health Knowledge, Attitudes, Practice, run by National University of Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Awareness of Coronary Heart Disease (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03744650, which also lists 24 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in